Clinical trial
Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the…
NCT00361374 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00361374 |
|---|---|
| Title | Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression |
| Official title | Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Cedars-Sinai Medical Center National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Dietary Supplement, Drug |
| Interventions | eicosapentaenoic acid, docosahexaenoic acid, Placebo |
| Enrollment | 196 |
| Start date | Jul 1, 2006 |
| Primary completion | Feb 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Aug 8, 2006 |
| Last update posted | Jul 18, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: